Phase 1 therapeutic trial for PNT6555, the lead of the pan-cancer PNT2004 fibroblast activation protein-alpha (FAP-alpha) inhibitor program, planned for…
--Planned Conditional Statistical Power Analysis was Conducted— --Primary Efficacy Study Endpoint Is Proportion of Patients that Die on Study Up…
PFIC caregivers reported high impact on mental and physical health, productivity, career prospects, sleep, relationships and financesStudy suggests PFIC caregivers’…
ANAHEIM, CA, Feb. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and…
London, United Kingdom and Toronto, Ontario--(Newsfile Corp. - February 14, 2022) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia"), a…
Toronto, Ontario--(Newsfile Corp. - February 14, 2022) - Green Shield Canada (GSC),and its Claim Watch fraud investigation team are joining…
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the company has once…
Funding round is led by Insight Partners to accelerate growth and fuel platform’s network expansion to meet surging demand COLUMBUS,…
Newest addition to company’s Zoom Stroke Solution allows for quick confirmation of successful clot retrieval during mechanical thrombectomy for ischemic…
STOCKHOLM, SWEDEN / ACCESSWIRE / February 14, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group AB (publ.) - announces that since the…